# data[].attributes.attachment_link.readable_text
O uso de antiagregantes plaquetários em pequenas doses diárias (75 a 100mg) tem sido recomendado para gestantes com risco aumentado para desenvolver pré-eclâmpsia (1). Os principais fatores de risco para o desenvolvimento da pré-eclâmpsia são primigestação, história prévia ou familiar, hipertensão crônica, diabetes, colagenose, raça negra, obesidade e trombofilias (1).
Seguem as recomendações a respeito deste tema na literatura:
Segundo o documento VI Diretrizes Brasileiras de Hipertensão, para prevenção da pré-eclâmpsia não se recomenda prescrever ácido acetilsalicílico (AAS) para gestantes normais, porém em mulheres com risco moderado e elevado de pré-eclâmpsia o uso de baixas doses pode ser útil, sendo iniciado na 12a à 14a semana de gestação (2). Para casos de hipertensão arterial crônica e hipertensão gestacional, o documento não faz menção ao uso de AAS.
De acordo com a Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO), em gestantes com antecedente de pré-eclâmpsia grave, principalmente restrição de crescimento fetal, eclâmpsia e síndrome HELLP, preconiza-se a administração precoce (a partir de 12 semanas de gestação) de AAS (100 mg/dia) ou cálcio (1,5 a 2 g/dia) até o final da gestação (3).
Já o Guideline da Sociedade Européia de Cardiologia recomenda baixas doses de AAS (75-100mg/dia) profilaticamente em mulheres com histórico de pré-eclâmpsia precoce em gestação anterior (< 28 semanas). Segundo esta referência, o AAS deverá ser administrado à noite, começando no período pré-concepção ou no diagnóstico da gestação (antes de 16 semanas de gestação), devendo ser continuado até o final da gestação (4).

Complementação da resposta
A hipertensão arterial é uma doença considerada problema de saúde pública pelo seu elevado custo médico-social (5). Ela complica cerca de 7 a 10% de todas as gestações (3), com prevalência variando conforme a faixa etária, sexo, raça, obesidade e presença de patologias associadas, tais como diabetes e doença renal. Nas mulheres em idade fértil a prevalência vai de 0,6 a 2,0%, na faixa etária de 18 a 29 anos, e de 4,6 a 22,3%, na faixa etária de 30 a 39 anos. Diferente dos países desenvolvidos, a hipertensão arterial na gestação permanece a primeira causa de morte materna direta no Brasil (37%), sendo a proporção maior nas regiões Norte e Nordeste em relação ao Sudeste, Sul e Centro-Oeste (5). É a complicação médica mais comum da gravidez e a principal causa de morbimortalidades materna e perinatal (3). A classificação das doenças hipertensivas na gestação mais aceita em nosso meio é a adotada pelo Grupo de Estudo da Hipertensão Arterial na Gravidez do Programa Nacional de Hipertensão Arterial (EUA) e pela Federação Brasileira de Ginecologia e Obstetrícia - FEBRASGO (BR). Além de utilizada como uma base de acesso à grávida hipertensa, também guia o planejamento de seus cuidados. Divide-se em:

1. Hipertensão crônica.

2. Pré-eclâmpsia/Eclâmpsia.

3. Pré-eclâmpsia superposta à hipertensão crônica.

4. Hipertensão gestacional.

O principal objetivo do tratamento é reduzir os riscos maternos e conseguir um bom resultado perinatal. A maioria das hipertensas de baixo risco não necessita de medicação anti-hipertensiva durante a primeira metade da gestação devido à redução fisiológica da pressão arterial neste período. O tratamento deve ser iniciado quando ocorrer aumento pressórico que possa provocar complicações maternas, objetivando manter a pressão sistólica entre 140-150mmHg e a diastólica entre 90-100mmHg (5).
A falta de estudos randomizados que possam avaliar os riscos e benefícios dos anti-hipertensivos na gestação faz com que a escolha se baseie mais na experiência pessoal e no consenso de especialistas. Não existe uniformidade de conduta nas sociedades nacionais, nem nas internacionais. A metildopa é a droga mais utilizada na gestação, seguida pela nifedipina e o labetalol (5).
Nos casos de hipertensas crônicas, o uso de AAS não comprovou redução de risco. A conclusão é que a indicação de seu uso profilático deva ser individualizada (5). Na eventualidade de surgirem dúvidas a respeito de sua indicação em determinado caso, o médico assistente dispõe do Canal 0800 do Telessaúde, através do telefone 0800 644 6543 (funcionando de segunda a sexta-feira, das 08 às 17:30h), que permite mais agilidade na tomada de decisão, resolvendo dúvidas em tempo real e sem necessidade de agendamento prévio.

Atributos da APS
Um dos fatores determinantes de um bom prognóstico perinatal para as gestantes com HAS é o início precoce do acompanhamento pré-natal qualificado (1).
É recomendável a educação continuada dos profissionais de saúde com enfoque na comunicação com a gestante, no preenchimento completo do cartão pré-natal e valorização deste como instrumento para identificar as gestantes de risco.
Entender que o fato da gestante ser hipertensa já denota a necessidade de uma intervenção diferenciada no pré-natal, com orientações acerca do manejo da doença e de suas possíveis complicações. Para tanto, é importante adequar o número de atendimentos no pré-natal, a fim de possibilitar maior tempo para esclarecimentos e orientações às gestantes (6).
Sem condições de prevenir a ocorrência de pré-eclâmpsia e suas manifestações clínicas é fundamental impedir a evolução da doença para as formas graves. Assim, o acesso de todas as gestantes à assistência pré-natal com qualidade tem sido a principal arma dos países desenvolvidos em diagnosticar precocemente a pré-eclâmpsia, reduzir a ocorrência de suas complicações e, consequentemente, as taxas de morbidade e mortalidade materna e perinatal decorrentes da mesma (3).
Importante destacar o papel de coordenação dos cuidados da APS, com acompanhamento compartilhado, nos casos em que haja necessidade de referenciar a gestante para um seguimento de pré-natal de alto risco. A coordenação de cuidados é um dos atributos da APS, e pode ser definida como a articulação entre os diversos serviços e ações relacionados à atenção em saúde de forma que, independentemente do local onde sejam prestados, estejam sincronizados e voltados ao alcance de um objetivo comum (7).

Bibliografia Selecionada

1. Duncan BB. Medicina ambulatorial: condutas de atenção primária baseadas em evidências. - 4a ed. Porto Alegre: Artmed; 2013.

2. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol [Internet]. 2010 [citado 2014 Dez 10];95(1 supl.1):1-51. Disponível em: http://publicacoes.cardiol.br/consenso/2010/Diretriz_hipertensao_ERRATA.pdf Acesso em: 19 fev 2015.

3. Febrasgo. Manual de Orientação Gestação de Alto Risco [Internet]. 2011 [citado 2014 Dez 10]. Disponível em: http://febrasgo.luancomunicacao.net/wp-content/uploads/2013/05/gestacao_alto-risco_30-08.pdf Acesso em: 19 fev 2015.

4. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [Internet]. [cited 2014 Dec 10]. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/early/2011/08/26/eurheartj.ehr218.full.pdf Acesso em: 19 fev 2015.

5. Tedoldi CL, Freire CMV, Bub TF, et al. Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia para Gravidez na Mulher Portadora de Cardiopatia. Arq Bras Cardiol [Internet]. 2009;93(6 supl.1):e110-e178. Disponível em: http://publicacoes.cardiol.br/consenso/2009/diretriz_card_grav_9306supl1.pdf Acesso em: 19 fev 2015.

6. Vettore MV, et al. Cuidados pré-natais e avaliação do manejo da hipertensão arterial em gestantes do SUS no Município do Rio de Janeiro, Brasil. Cad Saúde Pública [Internet]. 2011;27(5):1021-34. Disponível em: http://www.scielosp.org/pdf/csp/v27n5/19.pdf

7. Almeida PF. Estratégias de coordenação dos cuidados: fortalecimento da atenção primária à saúde e integração entre níveis assistenciais em grandes centros urbanos. 2010. Tese de Doutorado. Disponível em:
http://www.arca.fiocruz.br/xmlui/bitstream/handle/icict/2586/ENSP_Tese_Almeida_Patty.pdf?sequence=1 Acesso em: 19 fev 2015.

# data[].attributes.attachment_link.description
O uso de antiagregantes plaquetários em pequenas doses diárias (75 a 100mg) tem sido recomendado para gestantes com risco aumentado para desenvolver pré-eclâmpsia (1). Os principais fatores de risco para o desenvolvimento da pré-eclâmpsia são primigestação, história prévia ou familiar, hipertensão crônica, diabetes, colagenose, raça negra, obesidade e trombofilias (1).

# data[].attributes.headline
 Recomendações OMS 2013 Suplementação  ferro e ácido fólicoem gestantes 

# data[].attributes.subject
 Recomendações OMS 2013 Suplementação  ferro e ácido fólicoem gestantes 

# data[].attributes.attachment_link.readable_text
The American College of Obstetricians and Gynecologists' Committee on Obstetric Practice makes the following recommendations regarding the timing of umbilical cord clamping after birth:

In term infants, delayed umbilical cord clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life, which may have a favorable effect on developmental outcomes.

Delayed umbilical cord clamping is associated with significant neonatal benefits in preterm infants, including improved transitional circulation, better establishment of red blood cell volume, decreased need for blood transfusion, and lower incidence of necrotizing enterocolitis and intraventricular hemorrhage.

Given the benefits to most newborns and concordant with other professional organizations, the American College of Obstetricians and Gynecologists now recommends a delay in umbilical cord clamping in vigorous term and preterm infants for at least 30-60 seconds after birth.

There is a small increase in the incidence of jaundice that requires phototherapy in term infants undergoing delayed umbilical cord clamping. Consequently, obstetrician-gynecologists and other obstetric care providers adopting delayed umbilical cord clamping in term infants should ensure that mechanisms are in place to monitor and treat neonatal jaundice.

Delayed umbilical cord clamping does not increase the risk of postpartum hemorrhage.

Introduction

Before the mid 1950s, the term early clamping was defined as umbilical cord clamping within 1 minute of birth, and late clamping was defined as umbilical cord clamping more than 5 minutes after birth. In a series of small studies of blood volume changes after birth, it was reported that 80-100 mL of blood transfers from the placenta to the newborn in the first 3 minutes after birth ( 1, 2) and up to 90% of that blood volume transfer was achieved within the first few breaths in healthy term infants ( 3). Because of these early observations and the lack of specific recommendations regarding optimal timing, the interval between birth and umbilical cord clamping began to be shortened, and it became common practice to clamp the umbilical cord shortly after birth, usually within 15-20 seconds. However, more recent randomized controlled trials of term and preterm infants as well as physiologic studies of blood volume, oxygenation, and arterial pressure have evaluated the effects of immediate versus delayed umbilical cord clamping (usually defined as cord clamping at least 30-60 seconds after birth) ( 4, 5). Delayed umbilical cord clamping appears to be beneficial for term and preterm infants. In term infants, delayed umbilical cord clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life, which may have a favorable effect on developmental outcomes. In preterm infants, rates of intraventricular hemorrhage and necrotizing enterocolitis are lower, and fewer newborns require transfusion when delayed umbilical cord clamping is employed. This growing body of evidence has led a number of professional organizations to recommend delayed umbilical cord clamping in term and preterm infants. For example, the World Health Organization recommends that the umbilical cord not be clamped earlier than 1 minute after birth in term or preterm infants who do not require positive pressure ventilation. Recent Neonatal Resuscitation Program guidelines from the American Academy of Pediatrics recommend delayed umbilical cord clamping for at least 30-60 seconds for most vigorous term and preterm infants. The Royal College of Obstetricians and Gynaecologists also recommends deferring umbilical cord clamping for healthy term and preterm infants for at least 2 minutes after birth. Additionally, the American College of Nurse-Midwives recommends delayed umbilical cord clamping for term and preterm infants for 2-5 minutes after birth ( 6). The universal implementation of delayed umbilical cord clamping has raised concern. Delay in umbilical cord clamping may delay timely resuscitation efforts, if needed, especially in preterm infants. However, because the placenta continues to perform gas exchange after delivery, sick and preterm infants are likely to benefit most from additional blood volume derived from continued placental transfusion. Another concern is that a delay in umbilical cord clamping could increase the potential for excessive placental transfusion. To date, the literature does not show evidence of an increased risk of polycythemia or jaundice; however, in some studies there is a slightly higher rate of jaundice that meets criteria for phototherapy in term infants. Given the benefits to most newborns and concordant with other professional organizations, the American College of Obstetricians and Gynecologists now recommends a delay in umbilical cord clamping for at least 30-60 seconds after birth in vigorous term and preterm infants.

Neonatal Outcomes

Physiologic studies in term infants have shown that a transfer from the placenta of approximately 80 mL of blood occurs by 1 minute after birth, reaching approximately 100 mL at 3 minutes after birth ( 7-9). Initial breaths taken by the newborn appear to facilitate this placental transfusion ( 10). A recent study of umbilical cord blood flow patterns assessed by Doppler ultrasonography during delayed umbilical cord clamping ( 11) showed a marked increase in placental transfusion during the initial breaths of the newborn, which is thought to be due to the negative intrathoracic pressure generated by lung inflation. This additional blood supplies physiologic quantities of iron, amounting to 40-50 mg/kg of body weight. This extra iron has been shown to reduce and prevent iron deficiency during the first year of life ( 12). Iron deficiency during infancy and childhood has been linked to impaired cognitive, motor, and behavioral development that may be irreversible ( 13). Iron deficiency in childhood is particularly prevalent in low-income countries but also is common in high-income countries, where rates range from 5% to 25% (13).

A longer duration of placental transfusion after birth also facilitates transfer of immunoglobulins and stem cells, which are essential for tissue and organ repair. The transfer of immunoglobulins and stem cells may be particularly beneficial after cellular injury, inflammation, and organ dysfunction, which are common in preterm birth ( 14, 15). The magnitude of these benefits requires further study, but this physiologic reservoir of hematopoietic and pluripotent stem cell lines may provide therapeutic effects and benefit for the infant later in life ( 16).
Clinical Trials in Preterm Infants
A 2012 systematic review on timing of umbilical cord clamping in preterm infants analyzed the results from 15 eligible studies that involved 738 infants born between 24 weeks and 36 weeks of gestation (4). This review defined delayed umbilical cord clamping as a delay of more than 30 seconds, with a maximum of 180 seconds, and included some studies that also used umbilical cord milking in addition to delayed cord clamping. Delayed umbilical cord clamping was associated with fewer infants requiring transfusion for anemia (seven trials, 392 infants; relative risk [RR], 0.61; 95% confidence interval [CI], 0.46-0.81). There was a lower incidence of intraventricular hemorrhage (ultrasonographic diagnosis, all grades) (10 trials, 539 infants; RR, 0.59; 95% CI, 0.41-0.85) as well as necrotizing enterocolitis (five trials, 241 infants; RR, 0.62; 95% CI, 0.43-0.90) compared with immediate umbilical cord clamping. Peak bilirubin levels were higher in infants in the delayed umbilical cord clamping group, but there was no statistically significant difference in the need for phototherapy between the groups. For outcomes of infant death, severe (grade 3-4) intraventricular hemorrhage, and periventricular leukomalacia, no clear differences were identified between groups; however, many trials were affected by incomplete reporting and wide confidence intervals.

Outcome after discharge from the hospital was reported in a small study in which no significant differences were reported between the groups in mean Bayley II scores at age 7 months (corrected for gestational age at birth and involved 58 children) (4). In another study, delayed umbilical cord clamping among infants born before 32 weeks of gestation was associated with improved motor function at 18-22 months corrected age ( 17).
Clinical Trials in Term Infants
A 2013 Cochrane review assessed the effect of timing of umbilical cord clamping on term neonatal outcomes in 15 clinical trials that involved 3,911 women and their singleton infants (5). This analysis defined early umbilical cord clamping as clamping at less than 1 minute after birth and late umbilical cord clamping as clamping at more than 1 minute or when cord pulsation ceased. The reviewers found that newborns in the early umbilical cord clamping group had significantly lower hemoglobin concentrations at birth (weighted mean difference, -2.17 g/dL; 95% CI, -4.06 to -0.280) as well as at 24-48 hours after birth (mean difference -1.49 g/dL; 95% CI, -1.78 to -1.21). In addition, at 3-6 months of age, infants exposed to early umbilical cord clamping were more likely to have iron deficiency compared with the late cord clamping group (RR, 2.65; 95% CI, 1.04-6.73).

There was no difference in the rate of polycythemia between the two groups, nor were overall rates of jaundice different, but jaundice requiring phototherapy was less common among those newborns who had early umbilical cord clamping (2.74% of infants in the early cord clamping group compared with 4.36% in the late cord clamping group; RR, 0.62; 95% CI, 0.41-0.96). However, the authors concluded that given the benefit of delayed umbilical cord clamping in term infants, delayed cord clamping is beneficial overall, provided that the obstetrician-gynecologist or other obstetric care provider has the ability to monitor and treat jaundice.

Long-term effects of delayed umbilical cord clamping have been evaluated in a limited number of studies. In a single cohort, assessed from 4 months to 4 years of age (13, 18, 19), scores of neurodevelopment did not differ by timing of umbilical cord clamping among patients at 4 months and 12 months of age. At 4 years of age, children in the early umbilical cord clamping group had modestly lower scores in social and fine motor domains compared with the delayed umbilical cord clamping group (13).

Maternal Outcomes

Immediate umbilical cord clamping has traditionally been carried out along with other strategies of active management in the third stage of labor in an effort to reduce postpartum hemorrhage. Consequently, concern has arisen that delayed umbilical cord clamping may increase the risk of maternal hemorrhage. However, recent data do not support these concerns. In a review of five trials that included more than 2,200 women, delayed umbilical cord clamping was not associated with an increased risk of postpartum hemorrhage or increased blood loss at delivery, nor was it associated with a difference in postpartum hemoglobin level or need for blood transfusion (5). However, when there is increased risk of hemorrhage (eg, placenta previa or placental abruption), the benefits of delayed umbilical cord clamping need to be balanced with the need for timely hemodynamic stabilization of the woman (Table 1).

Process and Technique of Delayed Umbilical Cord Clamping

Delayed umbilical cord clamping is a straightforward process that allows placental transfusion of warm, oxygenated blood to flow passively into the newborn. The position of the newborn during delayed umbilical cord clamping generally has been at or below the level of the placenta, based on the assumption that gravity facilitates the placental transfusion ( 20, 21). However, a recent trial of healthy term infants born vaginally found that those newborns placed on the maternal abdomen or chest did not have a lower volume of transfusion compared with infants held at the level of the introitus ( 22). This suggests that immediate skin-to-skin care is appropriate while awaiting umbilical cord clamping. In the case of cesarean delivery, the newborn can be placed on the maternal abdomen or legs or held by the surgeon or assistant at close to the level of the placenta until the umbilical cord is clamped.

During delayed umbilical cord clamping, early care of the newborn should be initiated, including drying and stimulating for first breath or cry, and maintaining normal temperature with skin-to-skin contact and covering the infant with dry linen. Secretions should be cleared only if they are copious or appear to be obstructing the airway. If meconium is present and the baby is vigorous at birth, plans for delayed umbilical cord clamping can continue. The Apgar timer may be useful to monitor elapsed time and facilitate an interval of at least 30-60 seconds between birth and cord clamp.

Delayed umbilical cord clamping should not interfere with active management of the third stage of labor, including the use of uterotonic agents after delivery of the newborn to minimize maternal bleeding. If the placental circulation is not intact, such as in the case of abnormal placentation, placental abruption, or umbilical cord avulsion, immediate cord clamping is appropriate. Similarly, maternal hemodynamic instability or the need for immediate resuscitation of the newborn on the warmer would be an indication for immediate umbilical cord clamping (Table 1). Communication with the neonatal care provider is essential.

The ability to provide delayed umbilical cord clamping may vary among institutions and settings; decisions in those circumstances are best made by the team caring for the mother-infant dyad. There are several situations in which data are limited and decisions regarding timing of umbilical cord clamping should be individualized (Table 1). For example, in cases of fetal growth restriction with abnormal umbilical artery Doppler studies or other situations in which uteroplacental perfusion or umbilical cord flow may be compromised, a discussion between neonatal and obstetric teams can help weigh the relative risks and benefits of immediate or delayed umbilical cord clamping.

Data are somewhat conflicting regarding the effect of delayed umbilical cord clamping on umbilical cord pH measurements. Two studies suggest a small but statistically significant decrease in umbilical artery pH (decrease of approximately 0.03 with delayed umbilical cord clamping) ( 23, 24). However, a larger study of 116 infants found no difference in umbilical cord pH levels and found an increase in umbilical artery pO ₂ levels in infants with delayed umbilical cord clamping ( 25). These studies included infants who did not require resuscitation at birth. Whether the effect of delayed umbilical cord clamping on cord pH in nonvigorous infants would be similar is an important question requiring further study.
Umbilical Cord Milking
Umbilical cord milking or stripping has been considered as a method of achieving increased placental transfusion to the newborn in a rapid time frame, usually less than 10-15 seconds. It has particular appeal for circumstances in which the 30-60-second delay in umbilical cord clamping may be too long, such as when immediate infant resuscitation is needed or maternal hemodynamic instability occurs. However, umbilical cord milking has not been studied as rigorously as delayed umbilical cord clamping. A recent meta-analysis ( 26) of seven studies that involved 501 preterm infants compared umbilical cord milking with immediate cord clamping (six studies) or with delayed umbilical cord clamping (one study). The method of umbilical cord milking varied considerably in the trials in terms of the number of times the cord was milked, the length of milked cord, and whether the cord was clamped before or after milking. The analysis found that infants in the umbilical cord-milking groups had higher hemoglobin levels and decreased incidence of intraventricular hemorrhage with no increase in adverse effects. Subgroup analysis comparing umbilical cord milking directly with delayed umbilical cord clamping was not able to be carried out because of small numbers in those groups. Several subsequent studies have been published. A recent trial in term infants comparing delayed umbilical cord clamping with umbilical cord milking found that the two strategies had similar effects on hemoglobin and ferritin levels ( 27). Another recent trial evaluating infants born before 32 weeks of gestation found that among those infants born by cesarean delivery, umbilical cord milking was associated with higher hemoglobin levels and improved blood pressure compared with those in the delayed umbilical cord clamping group, but the differences were not seen among those born vaginally ( 28). Long-term (at age 2 years and 3.5 years) neurodevelopmental outcomes evaluated in one small study showed no difference between preterm infants exposed to delayed umbilical cord clamping compared with umbilical cord milking ( 29). This is an area of active research, and several ongoing studies are evaluating the possible benefits and risks of umbilical cord milking compared with delayed umbilical cord clamping, especially in extremely preterm infants. Currently, there is insufficient evidence to either support or refute umbilical cord milking in term or preterm infants.

Multiple Gestations

Many of the clinical trials that evaluated delayed umbilical cord clamping did not include multiple gestations; consequently, there is little information with regard to its safety or efficacy in this group. Because multiple gestations increase the risk of preterm birth with inherent risks to the newborn, these neonates could derive particular benefit from delayed umbilical cord clamping. Theoretical risks exist for unfavorable hemodynamic changes during delayed umbilical cord clamping, especially in monochorionic multiple gestations. At this time, there is not sufficient evidence to recommend for or against delayed umbilical cord clamping in multiple gestations.

Effect on Umbilical Cord Blood Banking

The effect of delayed umbilical cord clamping on umbilical cord blood collection for banking recently has been evaluated in a public umbilical cord blood bank setting ( 30). The authors found that delayed umbilical cord clamping significantly decreased the volume and total nucleated cell counts of cord blood donations. The proportion of units that met initial screening criteria decreased significantly from 39% with immediate umbilical cord clamping to 17% in cases in which there was a 60-second delay in umbilical cord clamping. In cases in which a patient and family are planning donation of umbilical cord blood, immediate cord clamping may increase the yield of cord blood obtained. However, in the absence of directed donation, the benefits to the infant of transfusion of additional blood volume at birth likely exceed the benefits of banking that volume for possible future use. Families who are considering banking of umbilical cord blood should be counseled accordingly.

Future Research

Although many randomized controlled trials that involved term and preterm infants have compared the benefits of delayed umbilical clamping with those of immediate cord clamping, the ideal timing for umbilical cord clamping in specific circumstances warrants further investigation. For example, infants requiring resuscitation may benefit considerably from placental transfusion, but their need for immediate attention raises questions about whether they should undergo immediate or delayed umbilical cord clamping and whether umbilical cord milking may offer a unique benefit. The feasibility of resuscitation at the bedside with intact placental circulation also is an important question. The optimal timing of uterotonic agents after birth in relation to umbilical cord clamping needs further study, as does the optimal practice in multiple gestations and pregnancies with risk factors for neonatal polycythemia. Finally, the value of enhanced stem cell and plasma transfusion associated with delayed umbilical cord clamping with respect to immediate and long-term immunity, host defense, and repair is another important area for future research.

Conclusion

Term and preterm infants appear to derive benefit from delayed umbilical cord clamping; therefore, delayed umbilical cord clamping for at least 30-60 seconds is recommended in term and preterm infants except when immediate umbilical cord clamping is necessary because of neonatal or maternal indications. In term infants, delayed umbilical cord clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life, which may have a favorable effect on developmental outcomes. There is a small increase in jaundice requiring phototherapy in term infants undergoing delayed umbilical cord clamping. Consequently, obstetrician-gynecologists and other obstetric care providers adopting delayed cord clamping in term infants should ensure that mechanisms are in place to monitor for and treat neonatal jaundice.

Similarly, evidence also supports delayed umbilical cord clamping for at least 30-60 seconds in preterm infants. Delayed umbilical cord clamping is associated with significant neonatal benefits in preterm infants, including improved transitional circulation, better establishment of red blood cell volume, decreased need for blood transfusion, and lower incidence of necrotizing enterocolitis and intraventricular hemorrhage.

In terms of maternal outcomes, delayed umbilical cord clamping does not increase the risk of postpartum hemorrhage or the need for blood transfusion. Additionally, postpartum maternal hemoglobin levels are not affected by delayed compared with immediate umbilical cord clamping.

References

1. Philip AG, Saigal S. When should we clamp the umbilical cord? Neoreviews 2004;5:e142-54. ⇦

2. Linderkamp O, Nelle M, Kraus M, Zilow EP. The effect of early and late cord-clamping on blood viscosity and other hemorheological parameters in full-term neonates. Acta Paediatr 1992;81:745-50. [PubMed] ⇦

3. Yao AC, Lind J. Effect of early and late cord clamping on the systolic time intervals of the newborn infant. Acta Paediatr Scand 1977;66:489-93. [PubMed] ⇦

4. Sanberg PR, Divers R, Mehindru A, Mehindru A, Borlongan CV. Delayed umbilical cord blood clamping: first line of defense against neonatal and age-related disorders. Wulfenia 2014;21:243-9. ⇦

# data[].attributes.attachment_link.title
Delayed Umbilical Cord Clamping After Birth

# data[].attributes.attachment_link.description
The American College of Obstetricians and Gynecologists' Committee on Obstetric Practice makes the following recommendations regarding the timing of umbilical cord clamping after birth: In term infants, delayed umbilical cord clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life, which may have a favorable effect on developmental outcomes.

# data[].attributes.body
Diretriz hemorragia pos parto dezembro 2016

# data[].attributes.attachment_link.description
Enter your email address below. If your address has been previously registered, you will receive an email with instructions on how to reset your password. If you don't receive an email, you should register as a new user

# data[].attributes.body
Pré Natal FEBRASGO 2014